1-7 of 7
George N. Naumov
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4716: First-in-class peroxiredoxin 3 (PRX3) inhibitor RSO-021 triggers mesenchymal-to-epithelial transition in mesothelioma

Terri Messier, Victoria Gibson, David J. Seward, Essa Y. Baitei, Peter Wells Jordan, Charlotte Poile, Joanna Dzialo, Aleksandra Bzura, Kudzayi Kutywayo, Apostolos Nakas, George N. Naumov, Dean A. Fennell, Brian Cunniff
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4716.
https://doi.org/10.1158/1538-7445.AM2024-4716
Published: 22 March 2024
View article titled, Abstract 4716: First-in-class peroxiredoxin 3 (PRX3) inhibitor RSO-021 triggers mesenchymal-to-epithelial transition in mesothelioma
Journal Articles

Abstract 384: SLC7A11 modulates sensitivity to the first-in-class mitochondrial peroxiredoxin 3 inhibitor thiostrepton (RSO-021) via a ferroptosis independent pathway

Terri Messier, Victoria Gibson, Aleksandra Bzura, Joanna Dzialo, Charlotte Poile, Stephanie Stead, Alexis Saaman, George N. Naumov, Dean A. Fennell, Brian Cunniff
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 384.
https://doi.org/10.1158/1538-7445.AM2024-384
Published: 22 March 2024
View article titled, Abstract 384: SLC7A11 modulates sensitivity to the first-in-class mitochondrial peroxiredoxin 3 inhibitor thiostrepton (RSO-021) via a ferroptosis independent pathway
Journal Articles

Abstract 4421: Onco Vasculomics(tm): A 3-d tumor vasculature assessment methodology for quantifying mechanism and efficacy of discovery-stage anti-cancer compounds.

Raul A. Brauner, Kongbin Kang, Yanchun Wu, George N. Naumov, John V. Heymach
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4421.
https://doi.org/10.1158/1538-7445.AM2013-4421
Published: 15 April 2013
View article titled, Abstract 4421: Onco Vasculomics(tm): A 3-d tumor vasculature assessment methodology for quantifying mechanism and efficacy of discovery-stage anti-cancer compounds.
Journal Articles

PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to Gefitinib

Jeffrey A. Engelman, Kreshnik Zejnullahu, Christopher-Michael Gale, Eugene Lifshits, Andrea J. Gonzales, Takeshi Shimamura, Feng Zhao, Patrick W. Vincent, George N. Naumov, James E. Bradner, Irene W. Althaus, Leena Gandhi, Geoffrey I. Shapiro, James M. Nelson, John V. Heymach, Matthew Meyerson, Kwok-Kin Wong, Pasi A. Jänne
Journal: Cancer Research
Cancer Res (2007) 67 (24): 11924–11932.
https://doi.org/10.1158/0008-5472.CAN-07-1885
Published: 18 December 2007
View article titled, PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with <em>EGFR</em> and <em>ERBB2</em> Mutations that Are Resistant to Gefitinib
Open the PDF for PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with <em>EGFR</em> and <em>ERBB2</em> Mutations that Are Resistant to Gefitinib in another window
Includes: Supplementary data
Journal Articles

Predicting the switch to the angiogenic phenotype in a human tumor model

Jay Harper, George N. Naumov, Alexis Exarhopoulos, Elise Bender, Gwendolyn Louis, Judah Folkman, Marsha A. Moses
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 837.
Published: 15 April 2006
View article titled, Predicting the switch to the angiogenic phenotype in a human tumor model
Journal Articles

An experimental animal model of human tumor dormancy

George N. Naumov, David A. Sampson, Elise R. Bender, David Zurakowski, Evelyn Flynn, Raanan Berger, Sarah Short, Giannoula Klement, Judah Folkman, Nava Almog
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1184.
Published: 01 April 2004
View article titled, An experimental animal model of human tumor dormancy
Journal Articles

Persistence of Solitary Mammary Carcinoma Cells in a Secondary Site: A Possible Contributor to Dormancy

George N. Naumov, Ian C. MacDonald, Pascal M. Weinmeister, Nancy Kerkvliet, Kishore V. Nadkarni, Sylvia M. Wilson, Vincent L. Morris, Alan C. Groom, Ann F. Chambers
Journal: Cancer Research
Cancer Res (2002) 62 (7): 2162–2168.
Published: 01 April 2002
View article titled, Persistence of Solitary Mammary Carcinoma Cells in a Secondary Site: <subtitle>A Possible Contributor to Dormancy</subtitle>
Open the PDF for Persistence of Solitary Mammary Carcinoma Cells in a Secondary Site: <subtitle>A Possible Contributor to Dormancy</subtitle> in another window